دورية أكاديمية
أعرض في EDS

Complicated Pleural Infection is Associated With Prolonged Recovery and Reduced Functional Ability.

التفاصيل البيبلوغرافية
العنوان: Complicated Pleural Infection is Associated With Prolonged Recovery and Reduced Functional Ability.
المؤلفون: Meggyesy AM; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA., Wilshire CL; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA., Bograd AJ; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA., Chiu ST; Medical Data Research Center, Providence Health and Services, Portland, OR., Gilbert CR; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA., Rahman NM; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Bedawi EO; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Vallieres E; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA., Gorden JA; Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA.
المصدر: Journal of bronchology & interventional pulmonology [J Bronchology Interv Pulmonol] 2024 Jul 22; Vol. 31 (4). Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101496866 Publication Model: eCollection Cited Medium: Internet ISSN: 1948-8270 (Electronic) Linking ISSN: 19488270 NLM ISO Abbreviation: J Bronchology Interv Pulmonol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Wolters Kluwer Health/Lippincott Williams & Wilkins
مواضيع طبية MeSH: Quality of Life*, Humans ; Male ; Female ; Middle Aged ; Aged ; Recovery of Function ; Surveys and Questionnaires ; Tissue Plasminogen Activator/therapeutic use ; Tissue Plasminogen Activator/administration & dosage ; Thrombolytic Therapy/methods ; Treatment Outcome ; Return to Work/statistics & numerical data ; Fibrinolytic Agents/therapeutic use ; Fibrinolytic Agents/administration & dosage ; Adult ; Pleural Diseases/therapy
مستخلص: Background: Management of complicated pleural infections (CPIs) had historically been surgical; however, following the publication of the second multicenter intrapleural sepsis trial (MIST-2), combination tissue plasminogen (tPA) and dornase (DNase) offers a less invasive and effective treatment. Our aim was to assess the quality of life (QOL) and functional ability of patients' recovery from a CPI managed with either intrapleural fibrinolytic therapy (IPFT) or surgery.
Methods: We identified 565 patients managed for a CPI between January 1, 2013 and March 31, 2018. There were 460 patients eligible for contact, attempted through 2 phone calls and one mailer. Two questionnaires were administered: the Short Form 36-Item Health Survey (SF-36) and a functional ability questionnaire.
Results: Contact was made in 35% (159/460) of patients, and 57% (90/159) completed the survey. Patients had lower QOL scores compared to average US citizens; those managed with surgery had higher scores in physical functioning (surgery: 80, IPFT: 70, P=0.040) but lower pain scores (surgery: 58, IPFT: 68, P=0.045). Of 52 patients who returned to work, 48% (25) reported an impact on their work effectiveness during recovery, similarly between management strategies (IPFT: 50%, 13/26 vs. surgery: 46%, 12/26; P=0.781).
Conclusion: Patients with a CPI had a lower QOL compared with average US citizens. Surgically managed patients reported improved physical functioning but worse pain compared with patients managed with IPFT. Patients returned to work within 4 weeks of discharge, and nearly half reported their ability to work effectively was impacted by their recovery. With further research into recovery timelines, patients may be appropriately counselled for expectations.
Competing Interests: Disclosure: There is no conflict of interest or other disclosures.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
References: Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest. 2000;118:1158–1171.
Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518–526.
Kheir F, Thakore S, Mehta H, et al. Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection randomized controlled clinical trial. Ann Am Thorac Soc. 2020;17:958–964.
Shin JA, Chang YS, Kim TH, et al. Surgical decortication as the first-line treatment for pleural empyema. J Thorac Cardiovasc Surg. 2013;145:933–939.e1.
Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133:346–351.e1.
Moores DWO. Management of acute empyema. Chest. 1992;102:1316–1317.
Shen KR, Bribriesco A, Crabtree T, et al. AATS consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153:e129–e146.
Casali C, Storelli ES, Di Prima E, et al. Long-term functional results after surgical treatment of parapneumonic thoracic empyema. Interact Cardiovasc Thorac Surg. 2009;9:74–78.
Cardillo G, Carleo F, Carbone L, et al. Chronic postpneumonic pleural empyema: Comparative merits of thoracoscopic versus open decortication. Eur J Cardiothorac Surg. 2009;36:914–918.
Metlay JP, Atlas SJ, Borowsky LH, et al. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med. 1998;92:1137–1142.
American Lung Association Scientific and Medical Editorial Review Panel. What causes pneumonia? American Lung Association. 2021. https://www.lung.org/lung-health-diseases/lung-disease-lookup/pneumonia/what-causes-pneumonia.
Mangen MJJ, Huijts SM, Bonten MJM, et al. The impact of community-acquired pneumonia on the health-related quality-of-life in elderly. BMC Infect Dis. 2017;17:208.
Wilshire CL, Jackson AS, Meggyesy AM, et al. Comparing initial surgery versus fibrinolytics for pleural space infections: a retrospective multicenter cohort study. Ann Am Thorac Soc. 2022;19:1827–1833.
36-Item short form survey (SF-36) scoring instructions. RAND Corporation. 2022. https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html.
Ware JE Jr, Kosinski M, Gandek B. The SF-36 health survey: manual and interpretation guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.
Wyrwich KW, Yu H, Sato R, et al. Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire. Patient Relat Outcome Meas. 2015;6:215.
Daniel P, Bewick T, McKeever TM, et al. Healthcare reconsultation in working-age adults following hospitalisation for community-acquired pneumonia. Clinical Medicine. 2018;18:41–46.
Labarere J, Stone RA, Obrosky DS, et al. Comparison of outcomes for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest. 2007;131:480–488.
Pick HJ, Bolton CE, Lim WS, et al. Patient-reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review. Eur Respir J. 2019;53:1802165.
Davydow DS, Hough CL, Levine DA, et al. Functional disability, cognitive impairment, and depression following hospitalization for pneumonia. Am J Med. 2013;126:615–624.
Council NR. Nonresponse in social science surveys: a research agenda. Washington D.C.: The National Academies Press; 2013. Epub ahead of print. doi:10.17226/18293.
Edelman LS, Yang R, Guymon M, et al. Survey methods and response rates among rural community dwelling older adults. Nurs Res. 2013;62:286–291.
Hayes V, Morris J, Wolfe C, et al. The SF-36 health survey questionnaire: Is it suitable for use with older adults? Age Ageing. 1995;24:120–125.
Kujawa A, Green H, Compas BE, et al. Exposure to COVID-19 pandemic stress: Associations with depression and anxiety in emerging adults in the United States. Depress Anxiety. 2020;37:1280–1288.
Liu CH, Stevens C, Conrad RC, et al. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among US young adults with suspected and reported psychiatric diagnoses. Psychiatry Res. 2020;292:113345.
المشرفين على المادة: EC 3.4.21.68 (Tissue Plasminogen Activator)
0 (Fibrinolytic Agents)
تواريخ الأحداث: Date Created: 20240722 Date Completed: 20240722 Latest Revision: 20240722
رمز التحديث: 20240722
DOI: 10.1097/LBR.0000000000000974
PMID: 39037060
قاعدة البيانات: MEDLINE
الوصف
تدمد:1948-8270
DOI:10.1097/LBR.0000000000000974